MUSPAGDU
Taiho Pharmaceutical Co., Ltd.
Application Filed: 2018-09-03
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79249249 |
| Registration Number | 5836981 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Howard N. Aronson |
| Attorney Docket Number | 21405 |
| Law Office Assigned | N20 |
| Employee Name | O'BRIEN, JENNIFER LYNN |
Timeline
| 2018-09-03 | Application Filed |
| 2019-06-04 | Published for Opposition |
| 2019-08-20 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-08-20 | Status: Live/Registered |
| 2019-08-20 | Trademark Registered |
| 2019-12-13 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  TAIHO PHARMACEUTICAL CO., LTD. |
| Address | 1-27 Kandanishiki-cho, Chiyoda-ku; Tokyo 101-8444 JP |
| Legal Entity Type | Corporation |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations, namely, pharmaceutical preparations for the treatment of inflammation |
| GS0051 | Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations, namely, pharmaceutical preparations for the treatment of inflammation |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2019-01-10 | 1 REPR M: |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2019-01-14 | 2 LIMI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-01-15 | 3 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2019-01-15 | 4 DOCK D:Assigned to Examiner |
| APPLICATION FILING RECEIPT MAILED | 2019-01-19 | 5 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2019-01-22 | 6 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2019-01-23 | 7 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2019-02-04 | 8 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2019-02-04 | 9 RFCS P: |
| CORRECTION TRANSACTION RECEIVED FROM IB | 2019-02-15 | 10 CRCV M: |
| REFUSAL PROCESSED BY IB | 2019-02-22 | 11 RFNP P: |
| CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | 2019-02-26 | 12 CORN I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-03-25 | 13 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-03-25 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-03-25 | 15 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-04-16 | 16 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2019-04-26 | 17 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-05-15 | 18 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2019-06-04 | 19 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-06-04 | 20 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2019-08-20 | 21 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2019-11-20 | 22 FICR P: |
| FINAL DISPOSITION PROCESSED | 2019-12-13 | 23 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2019-12-13 | 24 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2020-01-03 | 25 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 